Overall | High risk1 | Medium risk2 | Low risk3 | “staff”4 | p value* | |
---|---|---|---|---|---|---|
VRE vanA/vanB | ||||||
Number of patients at risk, N | 1096 | 280 | 342 | 430 | 44 | < 0.001 |
VRE-positive patients, N (%) | 25 (2.3) | 22 (7.9) | 2 (0.6) | 0 (0) | 1 (2.3) | |
VRE vanA ST375 | ||||||
Number of patients at risk, N | 681 | 120 | 295 | 262 | 4 | < 0.001 |
VRE-positive patients, N (%) | 8 (1.2) | 6 (5.0) | 2 (0.7) | 0 (0) | 0 (0.0) | |
VRE vanB ST117 | ||||||
Number of patients at risk, N | 486 | 169 | 89 | 188 | 40 | < 0.001 |
VRE-positive patients, N (%) | 17 (3.5) | 16 (9.5) | 0 (0) | 0 (0) | 1 (2.5) |